Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DexTech receives positive results regarding multiple myeloma

DexTech can announce that the company is expanding its preclinical program to also include research into the effect of OsteoDex on multiple myeloma, (MM), in vitro, cell cultures. MM is a malignant tumor disease of the bone marrow, which causes the skeleton to break down. MM is an incurable disease where a number of different treatments are used to slow down the process. The treatments often have severe side effects. The company sees OsteoDex as very promising for the treatment of MM based on its mechanism of action and mild side effects. In summary, a potent treatment effect is seen,

IKEA expands into Ukraine with Kyiv store opening

After successfully launching e-commerce in Ukraine in May 2020, IKEA and Ingka Group has further expanded its presence in the country with its first physical store in Kyiv.The city store format – which opened its doors today - is located at the Blockbuster Mall close to the heart of the capital, making it easily accessible for customers. The store’s convenience is key, helping bring IKEA closer to where people, live work and socialise .  “The Kyiv store opening is an important

Read original

Nexam Chemical intends to undertake a directed new share issue amounting to SEK 30 million

Nexam Chemical Holding AB (“Nexam Chemical” or the “Company”) today announces its intentions to carry out a directed new share issue of SEK 30 million to primarily Swedish and international institutional investors (the ”Directed New Share Issue”).The transaction in brief The Directed New Share Issue is intended to be carried out with deviation from the shareholders’ preferential rights and with the support of the authorization granted by the annual general meeting held on May 13, 2020. Nexam Chemical has engaged Erik Penser Bank (”Erik Penser Bank”) to investigate the conditions  for a

NoHo Partners provides further information about the progress of financing negotiations

NoHo Partners PlcSTOCK EXCHANGE RELEASE 1 February 2021 at 18:30NoHo Partners provides further information about the progress of financing negotiations On 10 November 2020, with the release of its interim report for the third quarter, NoHo Partners Plc announced that it will begin financing negotiations with its financers. The future financing package will secure the Group’s financial position over the coming years. The negotiations are coming to a close and they have progressed in a spirit of good mutual understanding. The Group will announce the outcome as soon as the

Essity raises EUR 700m in the bond market

Essity has today raised EUR 700m in the bond market under its Euro Medium Term Note (EMTN) program. The reoffering yield for the bond was 0.289% with a maturity on February 8, 2031, corresponding to mid swaps +0.47 percentage points.The bond offering was oversubscribed, and the transaction was placed with more than 100 investors.  The bonds will be listed on the Luxembourg Stock Exchange. The purpose of the issue is to refinance maturing bond loans and to finance operations.  Danske Bank, JP Morgan, Nordea, and UniCredit Bank acted as joint bookrunners for the transaction.

Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Nixu Corporation, Stock exchange release on February 1, 2021 at 17.42Nixu Corporation has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from OP-Rahastoyhtiö Oy (business ID 0743962-2) on February 1, 2021. According to the notification, the aggregate ownership of OP-Suomi Pienyhtiöt and OP-Suomi Mikroyhtiöt investment funds, managed by OP-Rahastoyhtiö Oy, in Nixu Corporation’s shares (ISIN: FI0009008387) increased above five (5) per cent threshold on January 29, 2021. Nixu has one share series and each share entitles its holder to one (1) vote.

#21-40 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-39 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Lehto Group Plc: Shareholders’ Nomination Committee’s proposals to the Annual General Meeting 2021

Lehto Group PlcStock exchange release1 February 2021 at 5.30 p.m. (EET)Lehto Group Plc Annual General Meeting is planned to be held on 28 May 2021. The Shareholder Nomination Committee’s gives the following proposals to the Annual General Meeting regarding the number, the composition, and the remuneration of the Members of the Board of Directors. The number of the Members of the Board of Directors The Shareholders’ Nomination Committee proposes that the number of Board members is six (6). The composition of the Members of the Board of Directors The Shareholders’ Nomination

REDEMPTION OF AXACTOR SE EUR 250,000,000 FRN SENIOR UNSECURED BOND ISSUE 2018/2021 - ISIN NO 001 0819725

The issuer has in a letter to the Bond Trustee on 29 January 2021 notified that the Issuer will exercise the Call Option to redeem all Outstanding Bonds under ISIN NO 001 0819725 with initial Maturity date 23 June 2021. The payment will be carried out as follows:  Redemption price:     100.0% of the Nominal Amount of each redeemed Bond, plus accrued interest Record Date:                 29 January 2021 New Maturity Date/Settlement Date:    5 February 2021   For additional information please contact: Kyrre Svae, Interim CFO, AxactorMobile phone: +47 478 39 405E-mail:

Fellow Finance platform facilitated 10.8 million euros of loans in January

FELLOW FINANCE PLC PRESS RELEASE 1.2.2021 AT 5:20 PMIn January, Fellow Finance's loan investors funded business and peer-to-peer loans worth of 10.8M€. Cumulative loan volume grew to 706 million euros and the total number of loan investors to 17 302. Check the real-time peer-to-peer lending statistics on our website: www.fellowfinance.com/for-investor/statistics. The performance of business and consumer loans, intermediated by Fellow Finance, can be followed on the company's website: www.fellowfinance.com/for-investor/statistics. The return index takes into account payment behaviour

Total Voting Rights

1 February 2021 15:00 GMT     Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 January 2021 the issued share capital of AstraZeneca PLC with voting rights is 1,312,698,568 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,312,698,568. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by

Invitation to presentation of LeoVegas fourth quarter 2020

LeoVegas report for the fourth quarter 2020 will be published at 08:00 CET on February 11, 2021. A webcast telephone conference will be held at 09:00 CET the same day, where Gustaf Hagman, CEO, and Stefan Nelson, CFO, will present the results. A possibility will be given to ask questions via the webcast and follow the presentation live. The webcast will be accessible at: · https://edge.media-server.com/mmc/p/hr4rjg4u To participate in the conference call by phone, please call one of the following numbers: · SE: +46 (0) 8 50 69 21 80 · UK: +44 (0) 20 71 92 80 00 · US:

Humana acquires Team J-son

Humana acquires the individual and family company Team J-son. The acquisition strengthens Humana as a provider of high-quality care services for children and youths with special needs in Sweden.Team J-son is a Swedish family business, founded in 1971, which offers individualised solutions for children and youths, age 10-23, with special needs. The operation includes housing, a school and a health team. The company is based in Jönköping and welcomes clients on a national basis. The company’s full-year revenue amounts to approximately SEK 90 million and the company has approximately 120

Attendo's year-end report for 2020 to be published on 10 February 2021 - Invitation to teleconference

On 10 February, around 08:00 am (CET), Attendo will present its year-end report and fourth quarter results for 2020. In connection with the report, updated financial targets are presented. Investors, analysts and journalists are invited to participate in a teleconference at 10:00 am (CET) on the same dateThe teleconference will be hosted by Attendo’s CEO Martin Tivéus and CFO Fredrik Lagercrantz. The presentation will be held in English. Date:   10 February 2021Time:   10:00 am (CET) To participate in the conference, please dial in on any number below at least ten minutes before the

Roar BidCo AB publishes a supplement to the offer document regarding its cash offer to the shareholders and Holders of Convertible Bonds in Recipharm AB (publ)

On 14 December 2020, EQT IX[1]  ("EQT IX"), through Roar BidCo AB[2] ("Roar BidCo"), announced a public offer to the shareholders and holders of the Senior Unsecured Convertible Bonds (the "Convertible Bonds") ("Holders of Convertible Bonds") in Recipharm AB (publ) ("Recipharm" or the "Company") to tender all their shares[3] and Convertible Bonds to Roar BidCo (the "Offer"). An offer document relating to the Offer was made public on 17 December 2020 (the "Offer Document"). On 28 January 2021, Roar BidCo announced an increase of the consideration offered in the Offer from SEK 220 to SEK

DOF ASA AND DOF SUBSEA AS: RESULT FROM BONDHOLDERS' MEETINGS

Reference is made to the summons to bondholders' meetings in DOFSUB07 (ISIN NO 001 0670144), DOFSUB08 (ISIN NO 001 078817.7) and DOFSUB09 (ISIN NO 001 083681.0) dated 15 January 2021 in which DOF Subsea AS requested an extension of the standstill period for the three bond loans initially until 31 March 2021 and with a possibility to extend to 30 June 2021 with the approval of an ad-hoc committee of bondholders. The bondholders' meetings were held today and the proposed resolution received 99.17%, 100% and 100% of the votes in DOFSUB07, DOFSUB08, and DOFSUB09, respectively. Approval of the

Composition of Herantis Pharma Plc's Shareholders' Nomination Committee

Herantis Pharma Plc Company release, 1 February 2021 at 3:30 p.m. EET The following members have been appointed to Herantis Pharma's Shareholders' Nomination Committee: · Marko Berg, Helsinki University Funds (HYR) (Chairman), · Pia Gisgard, Swedbank Robur, · Aki Prihti, Inveni Life Sciences Fund I Ky, ja · Timo Veromaa, the Chairman of Herantis Pharma's Board of Directors. Herantis Pharma's Shareholders' Nomination Committee consists of four members, of which three represent the company's shareholders. The Chairman of Herantis Pharma's Board of Directors will

Electrolux Nomination Committee’s proposal for election of board members

In preparation for the Electrolux Annual General Meeting on March 25, Electrolux Nomination Committee has decided to propose the re-election of all board members except Kai Wärn, who has declined re-election. Staffan Bohman is proposed to be re-elected as Chairman of the Board of Directors, and Petra Hedengran, Henrik Henriksson, Ulla Litzén, Karin Overbeck, Fredrik Person, David Porter and Jonas Samuelson as Board Members.The Nomination Committee comprises Johan Forssell (Chairman), Investor AB, Carina Silberg, Alecta, Tomas Risbecker, AMF – Försäkring och Fonder, and Marianne Nilsson,

There Are Still Worlds to Conquer in New Imperator: Rome Expansion

Heirs of Alexander DLC accompanied by Free Military UpdateSTOCKHOLM - 01 February 2021 - The career of Alexander III of Macedon was short and brilliant. In his decade-long war in Asia, Alexander’s fire burned a legend into the hearts of kings and conquerors who would follow. His death, however, meant civil war as comrade turned on comrade in an effort to claim the sacred mantle of the fallen king. Do you have what it takes to be the true Heir to Alexander’s legacy? Paradox Development Studio and Paradox Thalassic are happy to announce Heirs of Alexander, a new Content Pack for Imperator:

Recyclable and renewable solutions – an interview with TePe’s Senior Product Manager

Senior Product Manager Sophia Engqvist has a key role in TePe’s efforts to reach CO₂ neutrality for products and packaging in 2022. However, intense work is required to get there. – At TePe, we don’t just talk about sustainability. We make sure that there are real results, says Sophia.Sophia Engqvist and her team have the responsibility of advancing TePe's products, a task characterised by the company's focus on sustainable solutions. It’s an area of exciting development with many things happening at once. – We work every day to develop the product range, including packaging, towards

FINIX developing textile life cycle management application with Tokmanni

Tokmanni     Press release     1 February 2021 at 2:55 p.m. The Finix research project , led by Aalto University , is developing tools for ensuring the sustainability of textiles. In the spring, Tokmanni will launch a new clothing collection, which will be used to test a life cycle data management application being developed by FINIX. The multidisciplinary FINIX research project, which is funded by the Strategic Research Council , aims at systemic change in the textile sector. The

Six reasons clinicians choose Planmeca

Planmeca is one of the largest dental equipment manufactures in the world and a leader in digital dentistry. Here are some of the key reasons clinicians around the world have chosen our products to improve their daily workflows and offer the best possible care to their patients. 1. Everything you need – in one software We offer all the equipment needed at a modern digital dental clinic – from dental units to imaging devices and CAD/CAM solutions. The comprehensive Planmeca Romexis® software ties it all together and allows you to capture, view and process all types of

Recipharm and Medspray launch Resyca joint venture to exploit novel softmist technology for pharmaceutical applications

Global contract development and manufacturing organisation (CDMO), Recipharm, and Medspray BV, a manufacturer of high-tech spray nozzles, announce that they have now completed their joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the mouth and throat. Commenting on this, Jean-François Hilaire, EVP Strategy and Global Integration at

There are no items matching the current filter
There are no more items matching the current filter
Back to top